Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion-Reference-Cited by-同舟云学术

Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion

Published:2015-05 Issue:1-2 Volume:486 Page:99-111
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Haensler Jean,Probeck Patricia,Su Jin^ORCID,Piras Fabienne,Dalençon François,Cotte Jean-François,Chambon Véronique,Iqbal Shehzad M.,Hawkins Lynn,Burdin Nicolas

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. TLR4 agonists as immunomodulatory agents;Alderson;J. Endotoxin Res.,2006

2. Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations;Anderson;Colloids Surf. B Biointerfaces,2010

3. The importance of adjuvant formulation in the development of a tuberculosis vaccine;Baldwin;J. Immunol.,2012

4. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020);Baudner;Pharm. Res.,2009

5. New vaccines for neglected parasitic diseases and dengue;Beaumier;Transl. Res.,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine adjuvants: Tailoring innate recognition to send the right message;Immunity;2024-04

2. Research progress on emulsion vaccine adjuvants;Heliyon;2024-02

3. Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines;Pharmacological Research;2023-03

4. Cytomegalovirus Vaccines;Plotkin's Vaccines;2023

5. E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency;The Journal of Immunology;2022-11-15